 | Up a level |
Geering, Barbara; Stoeckle, Christina; Conus, Sébastien; Simon, Hans-Uwe (2013). Living and dying for inflammation: neutrophils, eosinophils, basophils. Trends in immunology, 34(8), pp. 398-409. Elsevier Current Trends 10.1016/j.it.2013.04.002
Schoepfer, Alain M; Gonsalves, Nirmala; Bussmann, Christian; Conus, Sébastien; Simon, Hans-Uwe; Straumann, Alex; Hirano, Ikuo (2010). Esophageal Dilation in Eosinophilic Esophagitis: Effectiveness, Safety, and Impact on the Underlying Inflammation. American journal of gastroenterology, 105(5), pp. 1062-1070. New York, N.Y.: Nature 10.1038/ajg.2009.657
Straumann, Alex; Conus, Sebastien; Degen, Lukas; Felder, Stephanie; Kummer, Mirjam; Engel, Hansjürg; Bussmann, Christian; Beglinger, Christoph; Schoepfer, Alain; Simon, Hans-Uwe (2010). Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology, 139(5), 1526-37, 1537.e1. Philadelphia, Pa.: Elsevier 10.1053/j.gastro.2010.07.048
Conus, Sébastien; Straumann, Alex; Bettler, Eva; Simon, Hans-Uwe (2010). Mepolizumab does not alter levels of eosinophils, T cells, and mast cells in the duodenal mucosa in eosinophilic esophagitis. Journal of allergy and clinical immunology, 126(1), pp. 175-7. St. Louis, Mo.: Mosby 10.1016/j.jaci.2010.04.029
Straumann, A; Conus, S; Grzonka, P; Kita, H; Kephart, G; Bussmann, C; Beglinger, C; Smith, D A; Patel, J; Byrne, M; Simon, H-U (2010). Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut, 59(1), pp. 21-30. London: BMJ Publishing Group 10.1136/gut.2009.178558
Conus, Sébastien; Perozzo, Remo; Reinheckel, Thomas; Peters, Christoph; Scapozza, Leonardo; Yousefi, Shida; Simon, Hans-Uwe (2008). Caspase-8 is activated by cathepsin D initiating neutrophil apoptosis during the resolution of inflammation. Journal of experimental medicine, 205(3), pp. 685-698. New York, N.Y.: Rockefeller University Press 10.1084/jem.20072152
